Sunday, June 5, 2016

AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting

… with malignant GBM, an aggressive brain cancer.
As of January 7 … and most aggressive form of brain cancer,
have a median survival … treatment options for this devastating brain cancer," said Martin van den …

No comments:

Post a Comment